Anxiety and substance use disorders are the most common co-occurring conditions seen in addiction treatment, and the relationship between them is not accidental. According to the Substance Abuse and Mental Health Services Administration (SAMHSA), roughly 9.5 million adults in the United States lived with both a mental health disorder and a substance use disorder in 2019, with anxiety disorders representing the single most prevalent mental health diagnosis in that group. Understanding how anxiety leads to substance abuse, and why the cycle is so difficult to break without professional support, is the first step toward getting the right kind of help.
What Is the Anxiety-Substance Abuse Connection
Anxiety disorders and substance use disorders frequently appear together, but the relationship runs in both directions. Anxiety does not simply cause addiction, and addiction does not simply cause anxiety. Each condition influences the other, often making both harder to recognize and treat.
A 2022 analysis published in the journal Frontiers in Psychiatry, drawing on data from over 36,000 adults, found that individuals with anxiety disorders were 2 to 3 times more likely to develop a substance use disorder than those without. The reverse also held: people with substance use disorders showed significantly elevated rates of generalized anxiety disorder, panic disorder, and social anxiety disorder compared to the general population.
What this means in practice is that anxiety and substance use are not separate problems that happen to share the same person. They are interacting conditions that reinforce each other over time, which is exactly why understanding what drives this overlap matters before any treatment can be effective.
How Anxiety Drives People Toward Substances
The self-medication hypothesis, formalized in research by Dr. Edward Khantzian and supported by decades of subsequent study, holds that people with untreated psychiatric symptoms turn to substances to manage distress the health system has not addressed. A 2018 study published in JAMA Psychiatry, following 34,653 adults over three years, found that individuals with anxiety disorders who did not receive mental health treatment were significantly more likely to develop alcohol use disorder than those who did, with the progression often beginning within the first year of untreated symptoms.
Anxiety does not feel abstract. It presents as racing thoughts that will not stop at night, a chest that stays tight in social situations, or a constant low-grade dread that makes ordinary tasks feel exhausting. When a substance appears to lift that weight, even briefly, the brain registers that relief as a solution. The pattern starts before a person has framed it as a problem.
To recognize this in your own experience: if you reach for alcohol, cannabis, or any other substance specifically when anxiety spikes, or use it to get through situations that feel overwhelming, the connection is already active.
The Role of the Brain’s Stress System
The hypothalamic-pituitary-adrenal axis, known as the HPA axis, is the brain’s central stress response system. In plain terms, it is the mechanism that floods your body with cortisol when you perceive a threat. In people with chronic anxiety, this system stays activated even when no real threat is present, leaving the nervous system in a near-constant state of alert. That translates to physical symptoms: elevated heart rate, shallow breathing, muscle tension, and difficulty sleeping.
Substances, particularly depressants like alcohol and benzodiazepines, temporarily suppress HPA axis activity. A 2020 study in Neuropsychopharmacology found that acute alcohol consumption reduced cortisol reactivity in adults with high trait anxiety, which is precisely why drinking feels calming. The brain’s reward pathway also responds to this suppression by releasing dopamine, reinforcing the behavior. The problem is that this suppression is short-lived, and the rebound effect reverses the relief entirely.
Which Substances People With Anxiety Reach For Most
Alcohol is the most commonly misused substance among people with anxiety, largely because it is legal, socially normalized, and produces rapid sedation. Benzodiazepines, prescribed directly for anxiety in many cases, carry a high risk of dependence precisely because they target the same GABA receptors that alcohol does. Cannabis is frequently reported as a calming agent, though a 2019 review in Psychological Medicine analyzing data from 83,000 participants found that regular cannabis use was associated with a 40 percent increased risk of developing an anxiety disorder over time.
Stimulants follow a less intuitive path. Some people with anxiety, particularly those who also have undiagnosed ADHD, report that stimulants produce a paradoxical calming effect rather than increased agitation. This pattern connects to how ADHD and substance use overlap in ways that are frequently misidentified by clinicians.
The substance that feels most calming in the short term tends to carry the highest long-term risk, because the more effectively a substance suppresses anxiety acutely, the more powerfully the brain encodes it as a necessary coping tool.
Why Short-Term Relief Creates Long-Term Harm
The feedback loop is straightforward and well-documented. A 2017 longitudinal study in Addiction, tracking 1,200 adults with anxiety over five years, found that participants who used alcohol to manage anxiety symptoms showed significantly higher anxiety severity at follow-up than those who did not, even after controlling for baseline anxiety levels. Substance use provides temporary relief, then withdrawal or tolerance resets the anxiety baseline at a higher level than before.
If your use has escalated over time, if you need more of a substance to get the same effect, or if anxiety spikes sharply when you go without, those are signs the feedback loop is already operating. The pattern of untreated mental health driving relapse cycles follows this same mechanism, which is why addressing the anxiety directly is non-negotiable in treatment.
How Substance Abuse Changes Anxiety in the Brain
Repeated substance use does not simply leave brain chemistry where it was. Chronic alcohol use downregulates GABA receptors, meaning the calming effect requires more alcohol to achieve. Simultaneously, it upregulates glutamate receptors, which drive excitation and anxiety. A 2021 study in Biological Psychiatry found that adults with alcohol use disorder showed measurably greater cortisol reactivity to mild stressors than non-dependent adults, a direct consequence of HPA axis dysregulation caused by repeated drinking and withdrawal cycles.
In practical terms: the anxiety you experience after regular substance use is neurologically more intense than the anxiety you started with. This is not a psychological weakness. It is a measurable change in receptor sensitivity and stress hormone reactivity. Trying to manage that level of anxiety without clinical support is genuinely harder than managing it would have been before substance use began.
The Withdrawal-Anxiety Spiral
Withdrawal from alcohol and benzodiazepines does not simply remove the substance from your system. It triggers acute anxiety symptoms that frequently exceed the original disorder in severity. A 2016 study in Alcohol and Alcoholism, following 312 adults through alcohol detox, found that 45 percent met the clinical threshold for a primary anxiety disorder during withdrawal, with symptoms persisting for weeks beyond acute detox.
This is why abrupt discontinuation without medical supervision so often fails. The anxiety produced by withdrawal feels unbearable, and the fastest available relief is the substance itself. Breaking that spiral requires medically supported detox, not willpower alone.
What a Dual Diagnosis Means for Your Treatment
A dual diagnosis, also called a co-occurring disorder, means two conditions are diagnosed and treated simultaneously: in this case, an anxiety disorder and a substance use disorder. This matters because treating only one condition without addressing the other produces substantially worse outcomes.
A 2019 meta-analysis in JAMA Psychiatry, reviewing 30 randomized controlled trials, found that integrated treatment addressing both conditions simultaneously produced significantly better outcomes than sequential treatment, where one condition was addressed before the other, across measures of sobriety, anxiety severity, and quality of life at twelve-month follow-up.
When evaluating a treatment program, the direct question to ask is: “Do you assess for and treat anxiety disorders concurrently with substance use, and does your clinical team include psychiatric support for both?” A yes to both is the baseline for effective dual diagnosis care.
Why Anxiety Disorders Are Frequently Missed
Substance use can mask anxiety symptoms or mimic them so closely that clinicians focus on the substance use alone. A 2020 study in Drug and Alcohol Dependence, analyzing intake data from 4,100 adults entering addiction treatment, found that fewer than 40 percent of those who met the criteria for a co-occurring anxiety disorder had received a formal anxiety diagnosis prior to treatment entry.
The practical consequence: do not assume that symptoms like racing thoughts, sleep disruption, physical tension, or social avoidance are purely substance-related. Report them accurately to any treatment provider even if you believe they are caused by withdrawal or intoxication. A thorough clinician will assess for the underlying disorder independently of the substance picture.
What Treatment for Anxiety and Substance Abuse Looks Like
Evidence-based treatment for co-occurring anxiety and substance use disorder centers on cognitive behavioral therapy adapted for dual diagnosis presentations, medication management when clinically appropriate, and structured care that addresses both conditions within the same program. A 2020 meta-analysis in Clinical Psychology Review, covering 27 trials and over 3,000 participants, found that integrated CBT for co-occurring anxiety and substance use disorders reduced both anxiety severity and substance use frequency significantly more than substance-focused treatment alone.
For adults managing work schedules, family responsibilities, or a step-down from residential care, structured outpatient treatment offers access to therapy, psychiatric evaluation, medication management, coping skills training, and individualized planning without requiring a complete pause from daily life. The key marker to look for in any program is a genuine dual diagnosis framework: separate assessments for anxiety and substance use, a clinician qualified to address both, and a treatment plan that names both conditions explicitly.
What to Try This Week
Track your anxiety and substance use together for seven days. Note when anxiety spikes, what you reach for, and how your anxiety level compares before and after. That record is the clearest evidence you can bring to a dual diagnosis assessment, and it is the most direct way to see the pattern for yourself before your first appointment.
Frequently Asked Questions
Can anxiety directly cause addiction?
Anxiety does not cause addiction in a simple, linear way, but it is a significant driver. People with untreated anxiety disorders are 2 to 3 times more likely to develop a substance use disorder. The mechanism is the self-medication cycle: anxiety creates distress, substances provide temporary relief, and the brain encodes that relief as a learned response worth repeating.
Is it possible to have anxiety and addiction at the same time?
Yes, and it is common. Co-occurring anxiety and substance use disorders are among the most frequently seen pairings in addiction treatment. The conditions interact: anxiety fuels substance use, and substance use worsens anxiety over time, particularly through the neurological changes caused by repeated use and withdrawal.
Does treating anxiety help with substance abuse?
Treating anxiety as part of an integrated program significantly improves substance use outcomes. The 2019 JAMA Psychiatry meta-analysis found that integrated treatment addressing both conditions outperformed single-condition treatment across all major outcome measures. Treating only the substance use while leaving anxiety unaddressed is one of the most common reasons for relapse.
Why does quitting alcohol or benzodiazepines make anxiety worse at first?
Chronic use of alcohol and benzodiazepines changes receptor sensitivity in the brain’s calming systems. When the substance is removed, those systems are left in a dysregulated state, producing withdrawal anxiety that is often more intense than the original disorder. This is a neurological consequence of receptor adaptation, not a sign that the anxiety was always this severe. Medical supervision during detox addresses this directly.
What should someone look for in a treatment program for both anxiety and addiction?
Look for a program that conducts separate clinical assessments for anxiety and substance use, employs psychiatric staff who can address both, offers therapy modalities proven for dual diagnosis presentations, and provides medication management where appropriate. An outpatient structure that accommodates work and family obligations is available and appropriate for many people at this level of care.
